Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Italian validation of the 12-item multiple sclerosis walking scale.

Solaro C, Trabucco E, Signori A, Cella M, Messmer Uccelli M, Brichetto G, Cavalla P, Gironi M, Patti F, Prosperini L.

Mult Scler Int. 2015;2015:540828. doi: 10.1155/2015/540828. Epub 2015 Mar 26.

2.

A global immune deficit in Alzheimer's disease and mild cognitive impairment disclosed by a novel data mining process.

Gironi M, Borgiani B, Farina E, Mariani E, Cursano C, Alberoni M, Nemni R, Comi G, Buscema M, Furlan R, Grossi E.

J Alzheimers Dis. 2015;43(4):1199-213. doi: 10.3233/JAD-141116.

PMID:
25201785
3.

Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.

Gironi M, Borgiani B, Mariani E, Cursano C, Mendozzi L, Cavarretta R, Saresella M, Clerici M, Comi G, Rovaris M, Furlan R.

J Immunol Res. 2014;2014:961863. doi: 10.1155/2014/961863. Epub 2014 Mar 26.

4.

Growth hormone and disease severity in early stage of multiple sclerosis.

Gironi M, Solaro C, Meazza C, Vaghi M, Montagna L, Rovaris M, Batocchi AP, Nemni R, Albertini R, Zaffaroni M, Bozzola M.

Mult Scler Int. 2013;2013:836486. doi: 10.1155/2013/836486. Epub 2013 Oct 23.

5.

A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis.

Gironi M, Saresella M, Rovaris M, Vaghi M, Nemni R, Clerici M, Grossi E.

Immun Ageing. 2013 Jan 10;10(1):1. doi: 10.1186/1742-4933-10-1.

6.

Comment on "Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosis".

Gironi M, Pasquariello N, Franchi S, Pucci M, Martinelli-Boneschi F, Solaro C, Centonze D, Martino G, Sacerdote P, Maccarrone M.

Brain Pathol. 2012 Jan;22(1):79. doi: 10.1111/j.1750-3639.2011.00511.x. Epub 2011 Sep 15. No abstract available.

PMID:
21707818
7.

Distinct cytokine patterns associated with different forms of chronic dysimmune neuropathy.

Gironi M, Saresella M, Marventano I, Guerini FR, Gatti A, Antonini G, Ceresa L, Morino S, Beghi E, Angelici A, Mariani E, Nemni R, Clerici M.

Muscle Nerve. 2010 Dec;42(6):864-70. doi: 10.1002/mus.21786.

PMID:
21104861
8.

Oxidative imbalance in different neurodegenerative diseases with memory impairment.

Gironi M, Bianchi A, Russo A, Alberoni M, Ceresa L, Angelini A, Cursano C, Mariani E, Nemni R, Kullmann C, Farina E, Martinelli Boneschi F.

Neurodegener Dis. 2011;8(3):129-37. doi: 10.1159/000319452. Epub 2010 Sep 13.

PMID:
20838029
9.

HLA-DRB1 polymorphisms distribution in chronic dysimmune polyneuropathy.

Gironi M, Guerini FR, Beghi E, Antonini G, Martinelli-Boneschi F, Ceresa L, Morino S, Agliardi C, Ferrante P, Nemni R.

Neuromuscul Disord. 2008 Dec;18(12):967-9. doi: 10.1016/j.nmd.2008.07.008. Epub 2008 Sep 11.

PMID:
18789688
10.

A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.

Gironi M, Martinelli-Boneschi F, Sacerdote P, Solaro C, Zaffaroni M, Cavarretta R, Moiola L, Bucello S, Radaelli M, Pilato V, Rodegher M, Cursi M, Franchi S, Martinelli V, Nemni R, Comi G, Martino G.

Mult Scler. 2008 Sep;14(8):1076-83. doi: 10.1177/1352458508095828.

PMID:
18728058
11.

Clinical and immunological worsening in a patient affected with Waldenstrom macroglobulinemia and anti-mag neuropathy after treatment with rituximab.

Gironi M, Saresella M, Ceresa L, Calvo M, Ferrante P, Merli F, Nemni R.

Haematologica. 2006 Jun;91(6 Suppl):ECR17. No abstract available.

12.

Procedure for the quantitative evaluation of motor disturbances in cerebellar ataxic patients.

Ferrarin M, Gironi M, Mendozzi L, Nemni R, Mazzoleni P, Rabuffetti M.

Med Biol Eng Comput. 2005 May;43(3):349-56.

PMID:
16035223
13.

Immunological patterns identifying disease course and evolution in multiple sclerosis patients.

Furlan R, Rovaris M, Martinelli Boneschi F, Khademi M, Bergami A, Gironi M, Deleidi M, Agosta F, Franciotta D, Scarpini E, Uccelli A, Zaffaroni M, Kurne A, Comi G, Olsson T, Filippi M, Martino G.

J Neuroimmunol. 2005 Aug;165(1-2):192-200.

PMID:
15949850
14.

Stiff person syndrome does not always occur with maternal passive transfer of GAD65 antibodies.

Nemni R, Caniatti LM, Gironi M, Bazzigaluppi E, De Grandis D.

Neurology. 2004 Jun 8;62(11):2101-2.

PMID:
15184624
15.

Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency.

Gironi M, Lamperti C, Nemni R, Moggio M, Comi G, Guerini FR, Ferrante P, Canal N, Naini A, Bresolin N, DiMauro S.

Neurology. 2004 Mar 9;62(5):818-20.

PMID:
15007142
16.

Beta endorphin concentrations in PBMC of patients with different clinical phenotypes of multiple sclerosis.

Gironi M, Furlan R, Rovaris M, Comi G, Filippi M, Panerai AE, Sacerdote P.

J Neurol Neurosurg Psychiatry. 2003 Apr;74(4):495-7.

17.

Caspase-1 levels in biological fluids from patients with multiple sclerosis and from patients with other neurological and non-neurological diseases.

Franciotta D, Martino G, Zardini E, Furlan R, Bergamaschi R, Gironi M, Bergami A, Angelini G, De Benedetti F, Pignatti P, Moscato G, Cosi V.

Eur Cytokine Netw. 2002 Jan-Mar;13(1):99-103.

18.

Immunological markers in multiple sclerosis.

Gironi M, Bergami A, Brambilla E, Ruffini F, Furlan R, Comi G, Martino G.

Neurol Sci. 2000;21(4 Suppl 2):S871-5. Review.

PMID:
11205366
19.

Cytokines and immunity in multiple sclerosis: the dual signal hypothesis.

Martino G, Furlan R, Brambilla E, Bergami A, Ruffini F, Gironi M, Poliani PL, Grimaldi LM, Comi G.

J Neuroimmunol. 2000 Sep 1;109(1):3-9. Review.

PMID:
10969174
20.

Occurrence of thyroid autoimmunity in relapsing remitting multiple sclerosis patients undergoing interferon-beta treatment.

Martinelli V, Gironi M, Rodegher M, Martino G, Comi G.

Ital J Neurol Sci. 1998 Apr;19(2):65-7.

PMID:
10935838

Supplemental Content

Loading ...
Support Center